Cumulative incidences of toxicities, infections, and relapse
| Cumulative incidence . | Treatment arm . | |||
|---|---|---|---|---|
| Etanercept, % (95% CI) . | Mycophenolate, % (95% CI) . | Denileukin, % (95% CI) . | Pentostatin, % (95% CI) . | |
| Day 56 grade 3-5 toxicity | 76 (64-89) | 80 (68-92) | 76 (64-89) | 67 (55-83) |
| Severe/life-threatening/fatal infections at day 270 | 47 (33-63) | 44 (30-59) | 62 (48-76) | 57 (42-72) |
| Relapse at day 180 | 15 (5-26) | 11 (2-21) | 15 (5-26) | 20 (7-33) |
| Cumulative incidence . | Treatment arm . | |||
|---|---|---|---|---|
| Etanercept, % (95% CI) . | Mycophenolate, % (95% CI) . | Denileukin, % (95% CI) . | Pentostatin, % (95% CI) . | |
| Day 56 grade 3-5 toxicity | 76 (64-89) | 80 (68-92) | 76 (64-89) | 67 (55-83) |
| Severe/life-threatening/fatal infections at day 270 | 47 (33-63) | 44 (30-59) | 62 (48-76) | 57 (42-72) |
| Relapse at day 180 | 15 (5-26) | 11 (2-21) | 15 (5-26) | 20 (7-33) |
Shown are the cumulative incidences (and 95% CIs) of toxicities, infections, and malignant disease relapse at the follow-up times shown. All grade 3 to 5 toxicities are shown regardless of reported attribution to study drug.